Principal Investigators

    HAMMELL, MOLLY C

    Institution

    COLD SPRING HARBOR LABORATORY

    Contact information of lead PI

    Country

    USA

    Title of project or programme

    Transposable Elements in Frontotemporal Lobar Degeneration

    Source of funding information

    NIH (NIA)

    Total sum awarded (Euro)

    484403.6697

    Start date of award

    01/07/2015

    Total duration of award in years

    4

    Keywords

    Frontotemporal Lobar Degenerations, protein TDP-43, DNA Transposable Elements, Retrotransposon, Amyotrophic Lateral Sclerosis

    Research Abstract

    ? DESCRIPTION (provided by applicant): The TDP-43 protein plays a role in a broad suite of neurodegenerative disorders including Frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis, and potentially Alzheimer’s disease. TDP-43 is a multifunctional protein with many known cellular roles. So while the importance of TDP-43 in neurodegeneration is established, the mechanisms of TDP-43 toxicity are unclear. We have discovered a new role for TDP-43 in regulating retrotransposons. Retrotransposons are virus-like sequences that are encoded in our genomes and are capable of replicating and inserting at new chromosomal positions. The toxic potential of transposons in the germline is established. So our discovery provides a plausible hypothesis for toxic effects of TDP-43 in neurons. Our preliminary studies provide evidence that TDP-43 normally helps to silence transposons and that this function is disrupted both in FTLD patients and a Drosophila disease model. Our proposed experiments will use next generation RNA-sequencing with brain samples from FTLD patients to profile expression of retrotransposons. We also will examine the small RNAS a chromatin mark that normally help to silence retrotransposons. We will test three specific hypotheses: 1- that retrotransposon expression is increased in FTLD and ALS brain tissue. 2- that small RNA silencing of retrotransposons is perturbed in FTLD and ALS brain 2- that H3K9me histone silencing mark is perturbed in FTLD and ALS brain tissue

    Further information available at:

Types: Investments < €500k
Member States: United States of America
Diseases: N/A
Years: 2016
Database Categories: N/A
Database Tags: N/A

Export as PDF